Galderma Group AG (SWX: GALD)

Galderma Group AG Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-14.2	-57.2	-98.5	-154.3
Depreciation & Amortization	241.9	236.9	251.1	239
Other Amortization	44.5	39.5	26.6	14.1
Loss (Gain) From Sale of Assets	-	-	0.7	-
Asset Writedown & Restructuring Costs	-0.4	0.6	15.2	18.7
Other Operating Activities	60.8	-20.2	-5.3	-17.7
Change in Accounts Receivable	-87.8	47.2	-66.9	-36.9
Change in Inventory	67.1	31.1	-127.4	-52.8
Change in Accounts Payable	8.4	-65.6	146.2	155.2
Change in Other Net Operating Assets	53.1	-46.9	-30.4	-39.9
Operating Cash Flow	419.4	165.4	111.3	195.7
Operating Cash Flow Growth	114.31%	48.61%	-43.13%	-
Capital Expenditures	-122.3	-121.3	-101.6	-49.9
Sale of Property, Plant & Equipment	3.4	3.4	-	-
Cash Acquisitions	-50	-25	-	-386.8
Sale (Purchase) of Intangibles	-80.9	-30.9	-57.9	-78.1
Investment in Securities	-	-	-	-8
Other Investing Activities	0.1	0.1	93	-
Investing Cash Flow	-250.7	-173.7	-66.5	-522.8
Long-Term Debt Issued	-	855.7	400	396
Long-Term Debt Repaid	-	-1,725	-472.1	-78.8
Net Debt Issued (Repaid)	-2,427	-869.7	-72.1	317.2
Issuance of Common Stock	2,438	1,011	-	-
Other Financing Activities	-35	-	-7.3	-10.7
Financing Cash Flow	-23.3	141.7	-79.4	306.5
Foreign Exchange Rate Adjustments	-5.7	0.3	-24.9	-16.5
Net Cash Flow	139.7	133.7	-59.5	-37.1
Free Cash Flow	297.1	44.1	9.7	145.8
Free Cash Flow Growth	103.77%	354.64%	-93.35%	-
Free Cash Flow Margin	6.88%	1.07%	0.25%	4.23%
Free Cash Flow Per Share	0.05	0.01	0.00	0.03
Cash Interest Paid	437.4	526.4	339.1	305.6
Cash Income Tax Paid	82.3	87.3	73.6	48.9
Levered Free Cash Flow	-	134.65	196.36	-
Unlevered Free Cash Flow	-	487.28	445.36	-
Change in Net Working Capital	-	16.8	-76.6	-

Source: S&P Capital IQ. Standard template. Financial Sources.